Moneycontrol PRO
HomeNewsBusinessStocksUnichem Laboratories hits 52-week low; receives EIR from USFDA for Ghaziabad unit

Unichem Laboratories hits 52-week low; receives EIR from USFDA for Ghaziabad unit

The company's formulation manufacturing facility at Ghaziabad has received an EIR from USFDA.

June 05, 2018 / 12:43 IST
Aurobindo Pharma Ltd.
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Shares of Unichem Laboratories touched 52-week low of Rs 233.30, down 3 percent intraday Tuesday as company received establishment inspection report (EIR) from United States Food and Drug Administration (USFDA).

    The company's formulation manufacturing facility at Ghaziabad has received an EIR from USFDA.

    The EIR from USFDA indicating closure of the inspection.

    The inspection was conducted by FDA in April 2018.

    At 12:37 hrs Unichem Laboratories was quoting at Rs 234.50, down Rs 5.90, or 2.45 percent.

    Posted by Rakesh Patil

    Moneycontrol News
    first published: Jun 5, 2018 12:43 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347